Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorilux and Efudex for scalp actinic keratoses
NCT03996252Phase 1Terminated
- Sponsor
- Tulane University
- Start
- Jul 2019
- Primary completion
- Jan 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of calcipotriol in actinic keratosis (AK), sponsored by Tulane University. Primary endpoint: Percentage of change in the number of scalp actinic keratoses from baseline at 8 weeks. Started Jul 2019; status: terminated.
02
Drugs
calcipotriol
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT03996252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03996252.